China's National Medical Products Administration held a supervisory meeting in
Beijing on inspection and remediation of medical device distribution and sales
channels. It instructed regulators at all levels to implement the "four most
stringent" requirements, adopt a problem‑driven approach, intensify risk
identification and remediation in commercial/distribution links, and severely
punish illegal conduct, push cleanup deeper to safeguard public devices
safety.
